In IBD, NLRP3 activation withinmacrophages and intestinal epithelial cells contributes to mucosal damage anddysbiosis; blockade of caspase-1 in murine colitis models ameliorates diseaseseverity. Here, NLRP3 is linked to inflammatory bowel disease.